MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia with Lewy bodies (DLB)"

  • 2017 International Congress

    Voxel-based Analysis of Cholinesterase Inhibitor Response in Lewy Body Disorders: A Prospective Observational Study

    J. Compagnone, H. Mustaerts, J. Li, M. Freedman, K. Galit, J. Lee, J. Kennedy, R. Chen, D. Tang-Wai, A. Lang, N. Herrmann, S. Black, M. Masellis (Toronto, ON, Canada)

    Objective: The objective is to investigate functional neuroimaging correlates of response to ChEIs in LBD. Background: Lewy body disorders (LBD), including dementia with Lewy bodies…
  • 2017 International Congress

    Defective visual perception in patients with Lewy body disease: assessment of hallucinations with pareidolia test.

    Y. Higashi, T. Tabuchi, M. Tabata (Himeji, Japan)

    Objective: Hallucination is a common feature in patients with advanced Parkinson’s disease(PD) and dementia with Lewy bodies (DLB). Background: The pareidolia test is a tool…
  • 2017 International Congress

    Feasibility, tolerability and acceptance of a psychosocial intervention for people with Parkinsonian dementia: The INVEST trial.

    S. McCormick, K. McDonald, S. Vatter, V. Orgeta, E. Poliakoff, S. Smith, M. Silverdale, B. Fu, I. Leroi (Manchester, United Kingdom)

    Objective: To compare a companion-guided, home-delivered psychosocial stimulation intervention to treatment as usual (TAU) to inform a large-scale efficacy trial for people with cognitive impairment…
  • 2017 International Congress

    A new psychosocial intervention for people with Parkinsonian dementias: Adherence, barriers and facilitators

    S. McCormick, K. McDonald, S. Vatter, V. Orgeta, E. Poliakoff, S. Smith, M. Silverdale, B. Fu, I. Leroi (Manchester, United Kingdom)

    Objective: To investigate participant adherence and engagement to a home-based, companion-guided cognitive stimulation therapy adapted for people with Parkinsonian dementias (CST-PD). Background: Adherence to rehabilitation…
  • 2017 International Congress

    Do Acetylcholinesterase Inhibitors (AChEI) delay institutionalisation in Parkinson’s and Lewy Body Disease?

    L. Brown, B. Mohamed, E. Thomas (Cardiff, United Kingdom)

    Objective: We explored the use of Rivastigmine in Parkinson’s and Lewy body dementia through assessment of quantitative data obtained from a clinical database. We focussed…
  • 2017 International Congress

    Glucocerebrosidase mutations in neurodegenerative disorders other than Parkinson’s disease

    G. Buongarzone, C. Fenoglio, J. Nicoli, E. Monfrini, I. Trezzi, A. Arighi, R. Del Bo, N. Bresolin, E. Scarpini, G. Comi, S. Corti, A. Di Fonzo (Milan, Italy)

    Objective: To determinate the frequencies of lysosomal glucocerebrosidase (GBA) common mutations in a large sample of neurodegenerative diseases including Alzheimer Disease (AD), Lewy Body Dementia (LBD), Amyotrophic…
  • 2017 International Congress

    Delusional Misidentification Syndrome for “Self” in two patients with Parkinson`s Disease.

    S. Ray, D. Park, D. Burdick, A. Griffith, J. Shaw, P. Agarwal (Kirkland, WA, USA)

    Objective:  We report two patients with Parkinson’s disease(PD) and Capgras syndrome (CS) with confusion of identify not just of close acquaintances but also of “self”.…
  • 2016 International Congress

    Musical ear syndrome as a presenting symptom of Lewy body disorder

    S.J. Song, D. Lee, Y.N. Kwon, T.B. Ahn (Seoul, Korea)

    Background: Musical ear syndrome (MES) or musical hallucination is non psychological phantom sound without auditory stimulation. MES is commonly reported in old people with hearing…
  • 2016 International Congress

    The Luxembourg Parkinson’s study: Integrating the Lewy body composite risk score into a longitudinal study

    M. Kerschenmeyer, P. Kolber, G. Hipp, K. Roomp, S.K. Mosch, A. Schweicher, L. Longhino, M. Falz, V.P. Satagopam, M. Gantenbein, M. Vaillant, F. Betsou, A. Chioti, R. Schreiner, R. Krüger (Belval, Luxembourg)

    Objective: To validate the LBCRS in a longitudinal national cohort study. The Lewy Body Composite Risk ScorePlease rate the following physical findings being present or…
  • 2016 International Congress

    Parkinsonism risk factors in Salt Lake City, Utah

    D. Shprecher, K. Gannon, M. Halverson, R. Savica (Sun City, AZ, USA)

    Objective: To assess the prevalence of risk factors for parkinsonism in Salt Lake City (SLC), Utah. Background: Recent data suggest that non-motor symptoms including constipation,…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley